Boussicault, L., Alves, S., Lamazière, A., Planques, A., Heck, N., Moumné, L., . . . Betuing, S. (2016). CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease. Brain.
Style de citation ChicagoBoussicault, Lydie, et al. "CYP46A1, the Rate-limiting Enzyme for Cholesterol Degradation, Is Neuroprotective in Huntington’s Disease." Brain 2016.
Style de citation MLABoussicault, Lydie, et al. "CYP46A1, the Rate-limiting Enzyme for Cholesterol Degradation, Is Neuroprotective in Huntington’s Disease." Brain 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.